Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-11-17

Clinical Trial Update: Milnacipran in the Treatment of Widespread, Non-Joint Pain in Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating milnacipran for widespread, non-joint pain in rheumatoid arthritis; the trial has completed and results were posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SAVELLA (milnacipran hydrochloride)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Arthritis, Rheumatoid | Phase 4 | Status: COMPLETED | Results posted: 2014-11-17